May 28, 2026—Seegene launched its new antimicrobial resistance testing product, the Allplex MDRO assay. The assay, which is CE marked under the EU in vitro diagnostic regulation, is designed to identify key multidrug-resistant pathogens and associated resistance genes in a single run and can support same-day reporting, depending on laboratory workflow. The Allplex MDRO assay complements the company’s Allplex Entero-DR assay, enabling a combined testing approach that covers antimicrobial-resistant enteric bacteria and additional high-risk MDRO targets.
Webinars and Sponsored Roundtables — Register Now
Wednesday, July 29, 2026, 1:00-2:00 PM ET
Learn about digital pathology technology that is future-ready, yet practical for today’s
laboratory needs.
Webinar presenters Scott Hammond, Senior Systems Consultant, Digital Pathology Division, Wexner Medical Center, Department of Pathology, and Ursula Hofer, Imaging Technologist, Pathology Digital Imaging Lab, Wexner Medical Center, Department of Pathology, and Sandra Banky, PA(ASCP), Director of Operations, Wexner Medical Center, Department of Pathology.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY